Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON (Reuters) - Europe's biggest biotechnology company, Denmark's Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

from Reuters: Health News http://ift.tt/2AfLONg